FDA 483 OBSERVATION · #721 OF 1,000 MOST-CITED
Provide space for examination
FDA cited this observation 28 times across 24 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
How FDA worded it — real examples
Failure to provide adequate space for private examinations of individuals to determine their eligibility as blood donors.
Failure to provide adequate space for private examinations of individuals to determine their eligibility as blood donors.
Failure to provide adequate space for private examinations of individuals to determine their eligibility as blood donors.
Failure to provide adequate space for private examinations of individuals to determine their eligibility as blood donors.
Failure to provide adequate space for private and accurate examinations of individuals to determine their eligibility as blood donors.
Failure to provide adequate space for examinations of individuals to determine their eligibility as blood donors.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.
Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.